Related Experiment Video
Updated: Oct 7, 2025

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs
Published on: December 22, 2023
Respiratory Support of Infants With Congenital Diaphragmatic Hernia
Emma Williams1, Anne Greenough1,2,3
1Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Insights
Optimizing respiratory support for infants with congenital diaphragmatic hernia (CDH) is crucial. Lung protective strategies are vital, while surfactant therapy and inhaled nitric oxide lack proven benefits in CDH patients.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Critical Care
Background:
- Congenital diaphragmatic hernia (CDH) causes severe lung hypoplasia and pulmonary vasculature abnormalities.
- This leads to ventilation-perfusion mismatch, impairing gas exchange in affected infants.
- Effective respiratory support is critical for initial stabilization and post-surgical recovery.
Purpose of the Study:
- To review and discuss optimal respiratory support strategies for infants with CDH.
- To evaluate current evidence regarding specific therapies like surfactant and inhaled nitric oxide.
- To explore potential benefits of novel ventilatory approaches.
Main Methods:
- Literature review focusing on respiratory management in CDH.
- Analysis of evidence for surfactant therapy and inhaled nitric oxide.
- Discussion of emerging ventilatory modalities.
Main Results:
- Lung protective ventilation is essential to prevent ventilator-induced lung injury and oxygen toxicity.
- Current evidence does not support routine surfactant therapy or inhaled nitric oxide for CDH.
- Pulmonary hypertension treatments are under investigation in clinical trials.
Conclusions:
- Lung protective ventilation strategies are paramount in managing infants with CDH.
- Further research is needed to establish the efficacy of novel ventilatory modalities like automated oxygen control, liquid ventilation, and heliox therapy.
Abstract:
Optimisation of respiratory support of infants with congenital diaphragmatic hernia (CDH) is critical. Infants with CDH often have severe lung hypoplasia and abnormal development of their pulmonary vasculature, leading to ventilation perfusion mismatch. It is vital that lung protective ventilation strategies are employed during both initial stabilisation and post-surgical repair to avoid ventilator induced lung damage and oxygen toxicity to prevent further impairment to an already diminished gas-exchanging environment. There is a lack of robust evidence for the routine use of surfactant therapy during initial resuscitation of infants with CDH and thus administration cannot be recommended outside clinical trials. Additionally, inhaled nitric oxide has been shown to have no benefit in reducing the mortality rates of infants with CDH. Other therapeutic agents which beneficially act on pulmonary hypertension are currently being assessed in infants with CDH in randomised multicentre trials. The role of novel ventilatory modalities such as closed loop automated oxygen control, liquid ventilation and heliox therapy may offer promise for infants with CDH, but the benefits need to be determined in appropriately designed clinical trials.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pulmonary Cycle: Exhalation
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Acute Respiratory Failure-III
Breathing

